[Migraine treatment].
Noth
J
J
Neurologische Klinik, Rheinisch-Westfälischen Technischen Hochschule, Aachen.
D000082:Acetaminophen / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004878:Ergotamine / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D012720:Severity of Illness Index; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D018712:Analgesics, Non-Narcotic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000932:Antiemetics; D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents; D000082:Acetaminophen; D004087:Dihydroergotamine; D004878:Ergotamine; D001241:Aspirin